<DOC>
	<DOC>NCT01108107</DOC>
	<brief_summary>This study will investigate - the effect of preoperative combination chemotherapy in patients with locally advanced colon cancer with mutation in the KRAS, BRAF or PIK3CA gene - the effect of preoperative combination chemotherapy in combination with biological treatment in patients without mutation in the KRAS, BRAF or PIK3CA gene.</brief_summary>
	<brief_title>Neoadjuvant Treatment of Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Histologically verified locally advanced T3 or T4 colon cancer assessed by CT scan Analysis of KRAS, BRAF, PIK3CA Age ≥18 år Performance status ≤ 2 Hematology ANC ≥ 1.5x10^9/l. Thrombocytes ≥ 100x10^9/l. Biochemistry Bilirubinaemia ≤ 3 x UNL. ALAT ≤ 5 x UNL Consent to translational research Fertile women must present a negative pregnancy test and use secure birth control during and 3 months after treatment. Written and orally informed consent. Clinically significant cardiovascular disease (including myocardial infarction, unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac arrhythmia) ≤ 1 year before enrollment, active severe infections or other concurrent disease. Peripheral neuropathy NCI grade &gt;1 Other malignant disease within 5 years prior to enrollment, except basal cell squamous carcinoma of the skin and cervical carcinomainsitu Other investigational treatment within 30 days prior to treatment start History of interstitial lung disease e.g. pneumonitis or pulmonary fibrosis or evidence of interstitial lung disease on baseline chest CT scan. Bleeding tumors Hypersensitivity to one or more of the substances</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Colon cancer</keyword>
	<keyword>Neoadjuvant treatment</keyword>
	<keyword>KRAS mutation</keyword>
	<keyword>BRAF mutation</keyword>
	<keyword>PIK3CA mutation</keyword>
	<keyword>Possibly avoid chemotherapy after operation</keyword>
</DOC>